183 related articles for article (PubMed ID: 23891978)
21. CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha.
Zhang S; Kodys K; Babcock GJ; Szabo G
Hepatology; 2013 Sep; 58(3):940-9. PubMed ID: 22577054
[TBL] [Abstract][Full Text] [Related]
22. Human hepatic stellate cells are not permissive for hepatitis C virus entry and replication.
Florimond A; Chouteau P; Bruscella P; Le Seyec J; Mérour E; Ahnou N; Mallat A; Lotersztajn S; Pawlotsky JM
Gut; 2015 Jun; 64(6):957-65. PubMed ID: 25063678
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice.
Scull MA; Shi C; de Jong YP; Gerold G; Ries M; von Schaewen M; Donovan BM; Labitt RN; Horwitz JA; Gaska JM; Hrebikova G; Xiao JW; Flatley B; Fung C; Chiriboga L; Walker CM; Evans DT; Rice CM; Ploss A
Hepatology; 2015 Jul; 62(1):57-67. PubMed ID: 25820364
[TBL] [Abstract][Full Text] [Related]
24. Identification of transferrin receptor 1 as a hepatitis C virus entry factor.
Martin DN; Uprichard SL
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10777-82. PubMed ID: 23754414
[TBL] [Abstract][Full Text] [Related]
25. Development of Hepatocyte-like Cell Derived from Human Induced Pluripotent Stem cell as a Host for Clinically Isolated Hepatitis C Virus.
Sa-Ngiamsuntorn K; Hongeng S; Wongkajornsilp A
Curr Protoc Stem Cell Biol; 2017 Aug; 42(1):4A.13.1-4A.13.34. PubMed ID: 28806853
[TBL] [Abstract][Full Text] [Related]
26. Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.
Fénéant L; Ghosn J; Fouquet B; Helle F; Belouzard S; Vausselin T; Séron K; Delfraissy JF; Dubuisson J; Misrahi M; Cocquerel L
PLoS One; 2015; 10(11):e0142539. PubMed ID: 26561856
[TBL] [Abstract][Full Text] [Related]
27. Single Particle Imaging of Polarized Hepatoma Organoids upon Hepatitis C Virus Infection Reveals an Ordered and Sequential Entry Process.
Baktash Y; Madhav A; Coller KE; Randall G
Cell Host Microbe; 2018 Mar; 23(3):382-394.e5. PubMed ID: 29544098
[TBL] [Abstract][Full Text] [Related]
28. Development of mouse hepatocyte lines permissive for hepatitis C virus (HCV).
Aly HH; Oshiumi H; Shime H; Matsumoto M; Wakita T; Shimotohno K; Seya T
PLoS One; 2011; 6(6):e21284. PubMed ID: 21731692
[TBL] [Abstract][Full Text] [Related]
29. Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors.
Bitzegeio J; Bankwitz D; Hueging K; Haid S; Brohm C; Zeisel MB; Herrmann E; Iken M; Ott M; Baumert TF; Pietschmann T
PLoS Pathog; 2010 Jul; 6(7):e1000978. PubMed ID: 20617177
[TBL] [Abstract][Full Text] [Related]
30. Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions.
Xia Y; Carpentier A; Cheng X; Block PD; Zhao Y; Zhang Z; Protzer U; Liang TJ
J Hepatol; 2017 Mar; 66(3):494-503. PubMed ID: 27746336
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition.
Li Q; Sodroski C; Lowey B; Schweitzer CJ; Cha H; Zhang F; Liang TJ
Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7620-5. PubMed ID: 27298373
[TBL] [Abstract][Full Text] [Related]
32. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
[TBL] [Abstract][Full Text] [Related]
34. Completion of the entire hepatitis C virus life cycle in genetically humanized mice.
Dorner M; Horwitz JA; Donovan BM; Labitt RN; Budell WC; Friling T; Vogt A; Catanese MT; Satoh T; Kawai T; Akira S; Law M; Rice CM; Ploss A
Nature; 2013 Sep; 501(7466):237-41. PubMed ID: 23903655
[TBL] [Abstract][Full Text] [Related]
35. Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle.
Li Q; Zhang YY; Chiu S; Hu Z; Lan KH; Cha H; Sodroski C; Zhang F; Hsu CS; Thomas E; Liang TJ
PLoS Pathog; 2014 May; 10(5):e1004163. PubMed ID: 24852294
[TBL] [Abstract][Full Text] [Related]
36. Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines.
Vogt A; Scull MA; Friling T; Horwitz JA; Donovan BM; Dorner M; Gerold G; Labitt RN; Rice CM; Ploss A
Virology; 2013 Sep; 444(1-2):1-11. PubMed ID: 23777661
[TBL] [Abstract][Full Text] [Related]
37. Occludin-Knockout Human Hepatic Huh7.5.1-8-Derived Cells Are Completely Resistant to Hepatitis C Virus Infection.
Shirasago Y; Shimizu Y; Tanida I; Suzuki T; Suzuki R; Sugiyama K; Wakita T; Hanada K; Yagi K; Kondoh M; Fukasawa M
Biol Pharm Bull; 2016 May; 39(5):839-48. PubMed ID: 26887345
[TBL] [Abstract][Full Text] [Related]
38. Species-specific regions of occludin required by hepatitis C virus for cell entry.
Michta ML; Hopcraft SE; Narbus CM; Kratovac Z; Israelow B; Sourisseau M; Evans MJ
J Virol; 2010 Nov; 84(22):11696-708. PubMed ID: 20844048
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse Model.
Shimizu Y; Shirasago Y; Kondoh M; Suzuki T; Wakita T; Hanada K; Yagi K; Fukasawa M
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437969
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of candidate virus receptors in human T lymphocytes prone or resistant to infection with patient-derived hepatitis C virus.
Sarhan MA; Chen AY; Michalak TI
PLoS One; 2013; 8(4):e62159. PubMed ID: 23626783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
